The Ozempic App Built Around the Weekly Shot Routine

MeAgain is the Ozempic app for keeping the whole week in one place, not just the shot itself. If you are already taking Ozempic, the app helps you track the weekly dose, the next shot day, side effects, food, water, weight, and the small patterns that are easy to forget by the weekend. The treatment view shows the medication graph, the checklist walks you through shot day, and the rotation map helps you avoid using the same area every week. Side effect logging covers the 18 most common GLP-1 side effects, plus unlimited custom symptoms with a 0-10 slider, and food logging gives you five ways to add meals. The Capybara widget keeps protein, water, fiber, and steps visible from the home screen. That gives you one view of the whole Ozempic week instead of bouncing between reminders, notes, and meal apps. MeAgain is trusted by 372,000+ users and has a 4.8-star App Store rating across over 16,000 ratings.

No. MeAgain does not sell branded Ozempic. It is the app people use to manage the weekly shot, food, symptoms, hydration, and weight while they are already taking Ozempic through their usual doctor and pharmacy. Inside the app, you can set your shot day, see the medication graph, log side effects on a 0-10 slider, rotate injection sites, and keep meals and weight in the same place. The app subscription is $10/month, and that is how MeAgain makes money. That's why the app stays the main product instead of turning into a drug-ordering page. The tracker works whether or not you ever use medication access through MeAgain. If an eligible subscriber later wants a separate self-pay path, the same app also includes an intake for compounded semaglutide at $129/month or compounded tirzepatide at $199/month through US-based 503A and 503B pharmacies after licensed clinician approval.

MeAgain supports the Ozempic dose schedule by making each step easy to see and easy to compare. Most people start at 0.25mg, then move to 0.5mg, 1mg, and 2mg over time, usually in four-week blocks. The app shows your current step, your next shot day, and a weekly medication graph so you can tell where you are at a glance. Each dose change stays tied to the same timeline as your symptom notes, food logs, and weight entries, which matters because the first week on a new dose often feels different from week three or four. Instead of trying to remember when nausea got better or when your appetite shifted, you can scroll back and see it. That running history is what turns MeAgain from a simple reminder into an Ozempic app you can actually use over months.

Yes. MeAgain lets you track Ozempic side effects in a way that shows patterns instead of leaving you with scattered notes. The app includes the 18 most common GLP-1 side effects, plus unlimited custom symptoms, including nausea, fatigue, constipation, heartburn, diarrhea, abdominal pain, and headache, and each one can be logged on a 0-10 severity slider with a timestamp. You can also add custom symptoms if your experience does not fit the default list. Over a few weeks, the tracker shows whether symptoms flare after dose changes, fade as your body adjusts, or keep repeating on the same days of the week. That matters because Ozempic side effects can feel random until you see them next to your shot history and medication graph. MeAgain keeps those pieces in one view, so you can spot the pattern and explain it more clearly when you talk with your doctor.

Start by downloading MeAgain from the App Store and setting up your shot schedule. Once you add your current dose and next shot day, the app can show the weekly medication graph, the countdown to your next injection, and the running history of symptoms, food, water, and weight. From there, the checklist helps on shot day, the rotation map remembers where you injected last, and the widget keeps protein, water, fiber, and steps visible during the rest of the week. The app subscription is $10/month, cancel anytime, with no upfront commitment. MeAgain is trusted by 372,000+ users and has a 4.8-star App Store rating across over 16,000 ratings. If medication access becomes important later, eligible subscribers can also use the in-app intake for compounded semaglutide or compounded tirzepatide through US-based 503A and 503B pharmacies.